Morning Trend | Shanghai Pharma remains weak and cautious, when will it welcome policy catalysts?
Shanghai Pharma (2607.HK) has recently shown weak price consolidation, remaining in a wait-and-see range overall. The daily MACD continues to show a death cross, and the main moving averages are still under pressure, indicating a cautious attitude in capital flow. The pharmaceutical sector lacks strong policy catalysts in the short term, combined with low market risk appetite, leading to a wait-and-see approach from major players. The company's fundamentals are relatively resilient, but increased competitive pressure and periodic policy regulation in the industry have resulted in limited performance growth elasticity. The technical bottom has not yet solidified, and the trading volume remains persistently low, indicating that major funds have not yet flowed in on a large scale. If there are significant policy benefits or industry event catalysts, short-term funds may react, driving a rapid rebound in stock prices. However, in the absence of clear positive factors, it is recommended that investors focus on controlling positions and defense, paying attention to intraday trading anomalies and changes in capital flow direction, and waiting for opportunities to act
Shanghai Pharma (2607.HK) has recently shown weak price consolidation, overall remaining in a wait-and-see range. The daily MACD continues to show a death cross, and the main moving averages are still under pressure, indicating a cautious attitude in capital flow. The pharmaceutical sector lacks strong policy catalysts in the short term, coupled with low market risk appetite, leading to a wait-and-see stance among major players.
The company's fundamentals are relatively resilient, but increased competitive pressure and periodic policy regulation in the industry have resulted in limited performance growth elasticity. The technical bottom has not yet solidified, and the trading volume remains persistently low, indicating that major funds have not yet flowed in on a large scale.
If there are significant policy benefits or industry events that act as catalysts, short-term funds may see unusual movements, driving a rapid rebound in stock prices. However, in the absence of clear positive news, it is recommended that investors focus on controlling positions and defense, paying attention to intraday trading fluctuations and changes in capital flow direction, and waiting for the right opportunity to act
